.

Make Better Decisions

  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

QuintilesIMS
Novartis
AstraZeneca
Johnson and Johnson
Mallinckrodt
Moodys
UBS
Harvard Business School
Chinese Patent Office
Citi

Generated: December 13, 2017

DrugPatentWatch Database Preview

Mechanism of Action: Thrombin Inhibitors

« Back to Dashboard

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Patent Submitted Product Substance Delist Req. Exclusivity Expiration
Hospira IncBIVALIRUDINbivalirudinINJECTABLE;INTRAVENOUS090811-001Jul 14, 2015APRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Fresenius Kabi UsaBIVALIRUDINbivalirudinINJECTABLE;INTRAVENOUS090189-001Oct 28, 2016APRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Dr Reddys Labs LtdBIVALIRUDINbivalirudinINJECTABLE;INTRAVENOUS201577-001May 26, 2017APRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Hospira IncBIVALIRUDINbivalirudinINJECTABLE;INTRAVENOUS090816-001Jul 14, 2015APRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Apotex IncBIVALIRUDINbivalirudinINJECTABLE;INTRAVENOUS204876-001Jul 6, 2017APRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
SandozARGATROBAN IN SODIUM CHLORIDEargatrobanINJECTABLE;IV (INFUSION)022485-001May 9, 2011APRXYesYes► Subscribe► Subscribe► Subscribe► Subscribe
Eagle PharmsARGATROBAN IN SODIUM CHLORIDEargatrobanINJECTABLE;IV (INFUSION)022434-001Jun 29, 2011RXYesYes► Subscribe► Subscribe► SubscribeY► Subscribe
Gland Pharma LtdARGATROBAN IN SODIUM CHLORIDEargatrobanINJECTABLE;IV (INFUSION)205570-001May 22, 2017APRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Eagle PharmsARGATROBAN IN SODIUM CHLORIDEargatrobanINJECTABLE;IV (INFUSION)022434-001Jun 29, 2011RXYesYes► Subscribe► Subscribe► SubscribeY► Subscribe
Teva Pharms UsaARGATROBAN IN 0.9% SODIUM CHLORIDEargatrobanINJECTABLE;IV (INFUSION)206769-001Dec 15, 2014RXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Novartis
Cantor Fitzgerald
McKesson
US Department of Justice
Farmers Insurance
AstraZeneca
Julphar
Merck
UBS
Moodys

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot